PET/MRI, CT metrics assess pathologic response of pancreas cancer to neoadjuvant therapy ...Middle East

According to an open-access Editor's Choice article in ARRS' American Journal of Roentgenology (AJR), post-neoadjuvant therapy (NAT) changes in metabolic metrics from PET/MRI and morphologic metrics from CT were associated with pathologic response and overall survival in patients with pancreatic ductal adenocarcinoma (PDA).

Hence then, the article about pet mri ct metrics assess pathologic response of pancreas cancer to neoadjuvant therapy was published today ( Wednesday 09/12/2020 - 10:30 PM ) and is available on ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( PET/MRI, CT metrics assess pathologic response of pancreas cancer to neoadjuvant therapy )

Also on site :

• The devil wears Old Navy? Inside Hollywood’s favorite movie marketing blitz
• India in talks with US and Iran on key port – Foreign Ministry
• How a Spanish startup pivoted to video AI and built a $230 million ARR business with no VC funding